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Purpose: To evaluate the association between patient’s knowledge of hypertension management and 
medication adherence.   
Methods: A cross-sectional study was undertaken with 385 hypertensive patients who visited outpatient 
departments in two public hospitals in Quetta City, Pakistan. Besides demographic and disease-related 
questions, two validated questionnaires (Hypertension Fact Questionnaire and Drug Attitude Inventory) 
were used for data collection. Descriptive statistics were to determine the demographic and disease 
characteristics of the patients while Spearman rank correlation was employed to measure the 
association between knowledge and drug adherence. 
Results: Out of 385 patients, 236 (61.3 %) of the patients had average knowledge about hypertension 
while 249 (64.7 %) were categorized as poor adherent. No patient was considered as good adherent in 
the study. Correlation coefficient between total score of knowledge and total adherence was – 0.170 (p 
< 0.001), indicating an inverse association between knowledge scores and adherence level. 
Conclusion: Although the level of knowledge was average, patients were unsure of the benefits of 
continuous medication use which resulted in non-adherence to regimens. Educating patients about the 
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INTRODUCTION 
 
Hypertension is a major global concern and is 
one of the key preventable risk factors for 
cardiovascular events. It has massive 
disturbing impact on the population’s health, 
resulting in unnecessary morbidity and 
mortality. Hypertension alone is held 
accountable for more than 5.8 % of death 
worldwide, loss of 11.9 % year of life and 
adjusted life of 1.4 %. The assessment, 
management and control of hypertension still 
carry a great challenge for health care 
researchers [1]. Within the context of 
hypertension management, a number of 
factors are targeted as influencing agents but 
non-adherence to treatment is still counted as 
one of the major contributing factors to poor 
management and control of hypertension.  
   
Adherence has multiple definitions but the 
essence remains the same in every 
statement. It is “the extent to which patients 
stay with the recommendations of health care 
professionals” [2]. Sometimes, compliance 
and concordance are also used for the same 
purpose but have been replaced, as 
adherence focuses on patients and follows 
an active approach. While focusing on 
chronic diseases in general and hypertension 
in particular, these recommendations include 
instructions about continuous use of 
medication, life style modification, home 
monitoring and self-assessment [3]. Being a 
decisive component in achieving success of 
therapy, adherence to antihypertensive 
medication has been a topic of interest for 
health care researchers [4,5] and based on 
the results and conclusions, various 
approaches have been developed and 
implemented [6]. A number of studies 
highlighted multiple issues in non-adherence, 
including knowledge about hypertension by 
patients towards hypertension; the outcomes 
are not encouraging as far as adherence to 
medication is concerned [7].  
 
The major population burden of the world is 
carried by Asia where the frequency of 
cardiovascular risk is also on the high side 
[8]. Very low degree of knowledge about 
hypertension and other cardiovascular 
conditions in the continent has often been 
reported [9]. Adequate data are not available 
on the extent of knowledge about 
hypertension and risk factors amongst 
Pakistanis, especially in those areas where 
incomes are low, including tribal areas, and 
among persons with no formal education and 
lack access to health facilities. Hypertension 
affects 23 % of the population, 18 % of 
persons aged > 15 years and 33 % of adults 
aged > 45 years [10]. Thus, the disease is 
emerging as a major clinical and public-
health problem in Pakistan.  
 
Another study revealed that 18 % of the 
people in Pakistan suffer from hypertension 
with every third person above 40 years of age 
becoming increasingly vulnerable to a wide 
range of diseases, including myocardial 
infarction, stroke, atrial fibrillation, heart 
failure and renal failure. It was also 
mentioned that only 50 percent of the people 
suffering from hypertension were diagnosed 
and that only half of those diagnosed were 
ever treated. Half of those treated for 
hypertension were prescribed correct 
medication to effectively control the condition. 
Thus only 12.5 % of hypertension cases were 
adequately controlled [11]. At the same time, 
a large proportion of the population is 
unaware of their condition, which is alarming.  
 
Therefore, the objective of this study was to 
investigate the association between 
knowledge about hypertension and 
medication adherence amongst patients in 




Study design and recruitment of subjects 
 
A cross-sectional, observational study was 
employed as the method of data collection. 
Based on the prevalence of hypertension, a 
sample of 385 hypertensive patients was 
selected between the months of September 
2009 and November 2009 from two tertiary 
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care hospitals in Quetta, Pakistan, namely, 
Sandamen Provisional Hospital and Bolan 
Medical Complex Hospital. Both of these 
institutions carry the major population burden 
from all over the province of Baluchistan with 
a large proportion of low income patients. 
 
The inclusion criteria were: patients at least 
18 years old, confirmed diagnosis of essential 
hypertension, those using antihypertensive 
agents for the last six months, and ability to 
speak and write in Urdu, the national 
language of Pakistan. The exclusion criteria 
were: patients aged < 18 and > 80 years, 
patients with co-morbidities, immigrants from 
other countries and pregnant women. 
 
Ethical issues  
 
As there was no human ethical committee for 
non-clinical studies in the said institutions, 
permission from the respective medical 
superintendents was obtained. Patients who 
agreed to participate were briefed on the 
nature and objectives of the study. Written 
and signed consent of the patients was 
obtained prior to data collection and this was 
followed by verification by the pharmacist 
working in cardiac units. The patients were 
assured of the confidentiality of their 
responses and their right to withdraw from 
the study with no penalty or consequences 




Two different questionnaires were used for 
the data collection. The Hypertension Fact 
Questionnaire (HFQ) was used to assess the 
level of knowledge and Drug Attitude 
Inventory (DAI-10) was used to measure the 
level of adherence of the hypertensive 
patients. Both instruments were pilot-tested 
with 40 established hypertensive patients for 
reliability and validity. The aim of the pilot 
study was to reveal difficulties in 
understanding the theme and meaning of the 
questions. Estimated amount of time of 
completion and willingness of the patients to 
participate in an interventional educational 
program was also taken into account. The 
data for patients involved in the pilot study 
was not taken into account in the main study.   
 
The instruments, originally constructed in 
English, were translated into the national 
language of Pakistan (Urdu) by a cardiologist 
with bilingual capabilities. It was made sure 
that the essential meanings of the items were 
preserved during translation. The translation 
was reconfirmed by a professor stationed at 
an academy of Urdu language. As the 
originality and consistency of the two 
instruments were stabilized, the final versions 
were reviewed and approved by the 
researchers. Little modification was 
necessary in order to improve 
comprehension by patients, but it was 
ensured that their original reliability and 
validity were retained. In addition to the two 
instruments, another form was also added to 
collect socio-demographic data that included 
age, gender, education, income, locality and 
duration of hypertension. Four pharmacists 
were trained to use HFQ and DAI-10 by the 
principal researcher and two cardiologists 
working in the respective hospitals. Focused 
group discussions were continuously held 
among the pharmacists, researchers and 
cardiologists to maintain the reliability of the 
data collection process. The data obtained 
were verified by the cardiologists and 
analyzed by the research team. 
 
Knowledge assessment tool 
 
HFQ, comprising 15 questions, was used to 
assess the knowledge of patients about 
hypertension, its causes, treatment and 
management. Each response was scored as 
‘yes’, ‘no’ or ‘do not know’. The HFQ was 
constructed by the research team after 
extensive literature survey [12,13]. The 
scoring range of HFQ was 15 (maximum) to 0 
(minimum). A cut off level of < 8 was 
considered as poor, 8-12 average, and 13-15 
as adequate, knowledge about hypertension. 
Knowledge scores for individuals were 
calculated and and summed up to give the 
total knowledge score. 
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Measurement of adherence 
 
DAI-10 (DAI) was used to measure the rate 
of drug adherence in the study patients. DAI 
consisted of 10 items with responses in the 
form of ‘yes’ or ‘no’, with scores ranging from 
10 as maximum to -10 as minimum [14,15]. 
Patients scoring in the negative range were 
considered non-adherent, 0 - 5 moderate 




Descriptive statistics were applied to compute 
the demographic and disease characteristics 
of the patients. All analyses were performed 
using SPSS version 16.0 (SPSS Inc., 
Chicago, IL). Spearman rank correlation test 
was used to measure the association 






HFQ and DAI-10 were pilot-tested with 40 
established hypertensive patients for 
reliability and validity (Cronbach ά = 0.70 for 
HFQ and 0.65 for DAI-10). The demographic 
characteristics of the study patients are 
presented in Table 1, including the frequency 
distribution of the study patients and disease-
related data. The mean age of the patients 
was 39.0 ± 6.6 years, 68.8 % of whom were 
males. The mean duration of hypertension 




Table 2 describes the responses of the 
patients to HFQ in descending order. The 
HFQ scores ranged between 0 and 15. 
Overall mean score was 8.03 ± 0.42 and 
median score 8. Out of the 385 patients 146 
(37.9 %) were within the poor knowledge 
range, 236 (61.3 %) moderate and only 3 
patients (0.8 %) showed adequate general 
knowledge about hypertension. Poor 
knowledge was apparent in responses to 
questions relating to onset and management 
(questions 3 and 5) and dietary control of 
hypertension (questions 11, 12 and 13) 
where correct answers to these questions 
were 27.8, 30.4, 13.5, 20.5 and 23.6 %, 
respectively. Correct answers, 96.4, 92.5, 
85.7 and 77.9 %, were highest in response to 
questions 7, 9, 15 and 1, respectively.  
 
Table 1: Characteristics of survey respondents 
(N=385) 
 
Characteristics Freq % 
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Pk Rs 5000- Pk Rs 10000 
Pk Rs 10000- Pk Rs 15000 













Disease duration (3.01± 0.94) 
< 1 year 
1-3 years 
3-5 years 
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The responses of the patients to DAI-10 
scale are provided in Table 3. The DAI-10 
test scores ranged between 10 and -10 with 
the overall mean score -1.74 ±2.154 and 
median score -2. Out of the 385 patients 249 
(64.7 %) were categorized as poor adherent  
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Table 2: Responses to hypertension knowledge items  
 
Hypertension knowledge item Yes (%) No (%) Don’t know (%) 
Do you know the normal values of blood pressure? 77.9 22.1 0.0 
Elevated BP is called hypertension 52.2 17.7 30.1 
Hypertension is a condition which can progress with age 27.8 70.1 2.1 
Both men and women have equal chance of developing 
hypertension 
20.3 79. 0.8 
Hypertension is a treatable condition 30.4 68.1 1.6 
The older a person is, the greater their risk of having 
hypertension 
67.3 31.2 1.6 
Smoking is a risk factor for hypertension 96.4 3.4 0.3 
Eating fatty food affects  blood cholesterol level which is a 
risk factor for developing hypertension 
41.0 48.6 10.4 
Being overweight increases risk for hypertension 92.5 7.5 0.0 
Regular physical activity will lower a person's chance of 
getting hypertension 
42.1 56.4 1.6 
Eating more salt has no effect on blood pressure 86.5 13.5 0.0 
Dietary approaches to reduce hypertension do no good 20.5 78.7 0.8 
White meat is as good as red meat in hypertension? 23.6 75.6 0.8 
Medication alone can control hypertension? 39.2 59.0 1.8 
Hypertension can lead to other life-threatening diseases? 85.7 11.7 2.6 
Note: Knowledge was assessed by giving 1 to correct answer and 0 to the wrong answer. The “don’t know” 
response was also taken as 0. The scale measured knowledge from maximum 15 to minimum 0. Scores < 
8 were taken as poor, 8 - 12 average, and 13 - 15 adequate knowledge of hypertension. Mean knowledge 
was 8.03 ±0.415. 
 
     Table 3: Drug adherence data  
 
Drug adherence item True (%) False (%) 
For me, the good things about medication outweigh the bad 58.4 41.6 
I feel uncomfortable on medication. 69.6 30.4 
I take medications of my own choice. 40.3 59.7 
Medications make me feel more relaxed. 60.3 39.7 
Medication makes me feel tired and sluggish. 84.4 15.6 
I take medication only when I am sick. 93.0 7.0 
I feel more normal on medication. 76.9 23.1 
It is unnatural for my mind and body to be controlled by medications. 40.0 60.0 
My thoughts are clearer on medication. 4.9 95.1 
By staying on medications, I can prevent getting sick. 60.0 40.0 
Note: Adherence was assessed by giving 1 to correct answer and -1 to the wrong answer. The scale 
measured adherence from a maximum of 10 to a minimum of -10. Any negative score was rated as poor 
adherence,,0 - 5 as moderate adherence and 6 - 10 as good adherent. Mean adherence was -1.74 ± 2.15. 
 
and 136 (35.3 %) as moderate  adherent to  
their therapies. No patient was considered 
good adherent. Poor adherence was 
apparent in responses to questions 9, 5 and 
2 where correct answers constituted 4.9, 15.6 
and 30.4 %, respectively. Correct answers, 
93.0 and 76.9 %, were highest in response to 
questions 6 and 7, respectively. 
The Spearman Rank order correlation 
coefficient between total score of knowledge 
and total adherence was – 0.170 (p < 0.001) 
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indicating an inverse association between 




Hypertension is the most prevalent non-
communicable disease in the society but 
sadly, control of the disease is suboptimal. 
Although the patients had average 
knowledge about hypertension, the level of 
adherence was poor. In the context of the 
Pakistani population, the effect of knowledge 
possessed by the patients on drug adherence 
is still uncertain as there was no previous 
study in the same area that can be compared 
with the present study. However, studies 
undertaken in some developed countries 
indicate mixed responses. In the present 
study, knowledge had inverse relationship to 
drug adherence, suggesting that there are 
other factors for the patients’ non-adherence 
which need to be explored.   
 
There is evidence that knowledge or 
information can indeed have an influence on 
the level of drug adherence. A number of 
studies support such an association in which 
a positive relationship was found between 
knowledge and adherence [16 17].  Studies 
that measure determinants in successful drug 
adherence do portray knowledge as one 
influencing factor in achieving good 
adherence to therapy [18]. In certain cases, 
knowledge is again highlighted to be 
associated with adherence but only under 
certain conditions and circumstances [19]. In 
contrast, there are also studies that found no 
association [20].  
 
The apparent reason for the conflicting 
outcomes and opinions may be due to 
differences in the concept and definition of 
adherence and knowledge. Sometimes, the 
effect of other factors cannot be discounted 
too. Since adherence is a multi–factor 
phenomenon, success or failure of therapy is 
not dependent on a single factor. Other 
factors such as age, gender, low 
socioeconomic status, prescribed drugs, 
posology, lack of social support, poor patient-
provider relationship, cost, forgetfulness, and 
presence of psychological problems 
(especially depression) should also be kept in 
mind and evaluated before coming to a 
conclusion [21].    
 
In the broader context of achieving optimal 
pharmaceutical care, one aspect stresses 
patients’ own understanding of disease, 
nature, management and treatment. This 
maximizes opportunity to exercise better 
control over the disease condition. In our 
case, a large proportion of the patients did 
not have a clear understanding of the disease 
they were suffering from, and had little 
information on treatment and management of 
hypertension. There is no established 
process of collaborative patient care as the 
key players in the health care system still 
bicker over roles and responsibilities, a 
situation that has adversely affected patient 
care services. Thus the interaction of the 
patient with the health care professional is 
rather limited which is probably one reason 
for poor adherence. It is high time that a 
patient-centred approach is adopted whereby 
the patient is involved in decision-making 
about his/her health. 
 
Another aspect of patient care revolves 
around the Health Belief Model which states 
that attitudes and beliefs of individuals can 
explain health behaviour [22]. In this model, 
perceived benefits and barriers in the health 
care regimen play a vital role in achieving 
therapeutic success. In our study, patients 
were seen making independent assessments 
of their disease, including its treatment and 
management, and were using different health 
systems (Ayurvedia and allopathy). This 
could be another reason for non-adherence 
to medication as multiple opinions from 
different health system alternatives as well as 
spiritual healers can complicate issues for the 
patient. Although some of the systems are 
not approved by the official authorities, their 
influence is pronounced in the population. 
The results notwithstanding, it is important 
that the patient should be educated on all 
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aspects of the phenomenon rather than on a 
single or a few issues. It should also be 
addressed by social and medical researchers 
foregoing achieve a fuller understanding of 
the underlying issues while the outcome of 
such studies should be utilized in policy and 
decision-making by government officials and 
members of the health care team. 
 
Limitations of the study 
 
One possible limitation of this study is that it 
may appear as an observational study on 
outpatients in public hospitals that are usually 
attended by low to middle income and 
uneducated population. The high income and 
educated group also utilizes the health 
facilities but usually in cases of emergency; 
at other times, they attend private health 
facilities. Thus, the results of our research 





Success of therapies is dependent upon the 
level of medication adherence carried out by 
patients. It is often believed that knowledge is 
one key factor in achieving better adherence. 
However, knowledge had an inverse relation 
in our cohort. It was also observed that 
patients had confusing perception of drug 
usage. Health care professionals can play a 
major role in this regard and a collaborative 
care approach should facilitate the education 
of patients about the benefits of medications 
and the importance of continuous medication 
use especially in the treatment and 
management of chronic diseases.  Further 
studies are also recommended to identify the 
major contributory factor to non-adherence.  
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